We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
+16.39%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$57.6M
Cap. Flow
-$60M
Cap. Flow %
-47.98%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$57.1M
2
MGNI icon
Magnite
MGNI
+$2.41M
3
NRX
NEPHROGENEX INC COM
NRX
+$495K

Sector Composition

Rank Sector Weight
1 Technology 32.71%
2 Healthcare 28.9%
3 Communication Services 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IL
1
DELISTED
IntraLinks Holdings Inc.
IL
$40.9M 32.71%
6,290,503
– –
EVDY
2
DELISTED
Everyday Health, Inc.
EVDY
$32.4M 25.89%
4,107,522
– –
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$358M
$19.6M 15.64%
656,948
– –
TVRD
4
Tvardi Therapeutics
TVRD
$24M
$14.8M 11.8%
85,224
– –
RLOC
5
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$11.7M 9.35%
2,570,395
– –
MGNI icon
6
Magnite
MGNI
$2.57B
$3.93M 3.14%
287,699
-149,691
-34% -$2.41M
SENS icon
7
Senseonics Holdings Inc
SENS
$254M
$1.82M 1.46%
23,140
– –
XCOM
8
DELISTED
XTERA COMMUNICATIONS INC COM STK (DE)
XCOM
$12K 0.01%
13,366
– –
NRX
9
DELISTED
NEPHROGENEX INC COM
NRX
– –
-1,052,966
Closed -$495K
ANAC
10
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
– –
-1,067,892
Closed -$57.1M

Similar funds

LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

Rho Capital Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Rho Capital Partners held 10 positions worth $125M, down 32% from $183M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners withdrew a net $60M in Q2 2016, closing 2 positions and reducing 1 holding. Its most notable exit was ANACOR PHARMACEUTICALS INC COM, an estimated $57.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.

  • Rho Capital Partners's biggest Q2 2016 reduction was Magnite, cutting an estimated $2.41M.
  • Rho Capital Partners fully exited ANACOR PHARMACEUTICALS INC COM in Q2 2016, selling an estimated $57.1M.
  • Rho Capital Partners's ten largest holdings make up 100% of its $125M portfolio in Q2 2016.
  • Rho Capital Partners opened 0 new positions and closed 2 in Q2 2016.
  • Rho Capital Partners's portfolio value fell 32% quarter-over-quarter to $125M.

Based on Rho Capital Partners's 13F filing for Q2 2016, filed 13 Jul 2016.